Dopamine D4-like receptors in vertebrate retina: Does the retina offer a model for the D4-receptor analysis?

Polish Journal of Pharmacology

Volumn 49, Issue 4, 1997, Pages 201-211

  Zawilska, Jolanta B ^a,b   Nowak, Jerzy Z ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

D4 receptors; Dopamine; Melatonin; Serotonin N acetyltransferase; Vertebrate retina

Indexed keywords

ADENYLATE CYCLASE; DOPAMINE; DOPAMINE 4 RECEPTOR; MELATONIN; RECEPTOR SUBTYPE; SEROTONIN N ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; DRD5 PROTEIN, HUMAN;

GENE EXPRESSION; HUMAN; NONHUMAN; PHOTORECEPTOR; RECEPTOR DENSITY; RETINA; REVIEW; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CHICKEN; CIRCADIAN RHYTHM; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIGHT; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CHICKENS; CIRCADIAN RHYTHM; CYCLIC AMP; DOPAMINE; DOPAMINE AGENTS; GENE EXPRESSION REGULATION; HUMANS; LIGHT; MELATONIN; MOLECULAR SEQUENCE DATA; PHOTORECEPTORS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; RETINA;

EID: 0030608918     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. 4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res., 1997, 752, 26-34.
2. 4 receptor variants. J. Neurochem., 1995, 65, 1157-1165.
3. 4 antagonists. J. Med. Chem., 1996, 39, 1946-1948.
4. Brann M. R., Young S. W.: Dopamine receptors are located on rods in bovine retina. Neurosci. Lett., 1986, 69, 221-226.
5. 4 receptors coupled to adenylate cyclase. Proc. Nat. Acad. Sci. USA, 1992, 89, 12093-12097.
6. Dawis S. M., Niemeyer G.: Dopamine influences the light peak in the perfused mammalian eye. Invest. Ophthalmol. Visual Sci., 1986, 27, 330-335.
7. 4 dopamine receptor in rat brain with sequence-specific antibodies. Mol. Brain Res., 1997, 45, 1-12.
8. Djamgoz M. B. A., Wagner H. J.: Localization and function of dopamine in the adult vertebrate retina. Neurochem. Int., 1992, 20, 139-191.
9. Florijn W. J., Tarazi F. I., Creese I.: Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther., 1997, 280, 561-569.
10. Goldstein M., Deutch A. Y.: Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J., 1992, 6, 2413-2421.
11. Hartman D. S., Civelli O.: Molecular attributes of dopamine receptors: new potential for antipsychotic drug development. Ann. Med., 1996, 28, 211-219.
12. Hartman D., Monsma F., Civelli O.: Interaction of antipsychotic drugs with dopamine receptor subtypes. In: Handbook of Experimental Pharmacology, Vol. 120. Ed. Csernansky J. G., Springer-Verlag, New York, 1996, 43-75.
13. 4 receptors. Brit. J. Pharmacol., 1996, 117, 1625-1632.
14. 2 dopamine receptor in frog retina that decreases cyclic AMP accumulation and serotonin N-acetyltransferase activity. Life Sci., 1986, 38, 331-342.
15. Iuvone P. M.: Cell biology and metabolic activity of photoreceptor cells: light-evoked and circadian regulation. In: Neurobiology and Clinical Aspects of the Outer Retina. Eds. Djamgoz M. B. A., Archer S. N., Vallerga S., Chapman & Hall, London, 1995, 25-55.
16. Iuvone P. M.: Molecular and cellular regulation of retinal serotonin N-acetyltransferase by circadian clocks, light, and dopamine. The Photic System and Time Measurement in Vertebrates (9-11 July, 1997), Poitiers, France; Abs. 1.
17. Iuvone P. M., Boatright J. H., Bloom M. M.: Dopamine mediates the light-evoked suppression of serotonin N-acetyltransferase activity in retina. Brain Res., 1987, 418, 314-324.
18. Jaber M., Robinson S. W., Missale C., Caron M. G.: Dopamine receptors and brain function. Neuropharmacology, 1996, 35, 1503-1519.
19. Kebabian J. W., Calne D. B.: Multiple receptors for dopamine. Nature, 1979, 277, 93-96.
20. Krizaj D., Witkovsky P.: Effects of submicromolar concentrations of dopamine on photoreceptor to horizontal cell communication. Brain Res., 1993, 627, 122-128.
21. 4 receptor. J. Med. Chem., 1996, 39, 1941-1942.
22. 4 receptors expressed in CHO cells. Life Sci., 1997, 60, 91-100.
23. 4 receptor. J. Neurochem., 1997, 68, 804-812.
24. 1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: Evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system. Proc. Nat. Acad. Sci. USA, 1988, 85, 4567-4571.
25. 4 receptors in GABAergic neurons of the primate brain. Nature, 1996, 381, 245-248.
26. 4 receptor. Mol. Brain Res., 1995, 29, 157-162.
27. 4 receptor selective antagonist. J. Pharmacol. Exp. Ther., 1996, 279, 1392-1403.
28. Müller P., Seeman P.: Dopaminergic sensitivity after neuroleptics: time course and specificity. Psychopharmacology, 1978, 60, 1-11.
29. 4 receptors. Eur. J. Pharmacol., 1997, 319, 379-383.
30. 2-like receptor subtype in the rat retina: biochemical and histochemical evidence. J. Neurochem., 1996, 67, 2514-2520.
31. 3H]dopamine release from the rabbit retina evoked by light, potassium, and electrical-stimulation. Med. Sci. Res., 1988, 16, 1073-1075.
32. Nowak J. Z., Arbilla S., Galzin A. M., Langer S. Z.: Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. J. Pharmacol. Exp. Ther., 1983, 226, 558-564.
33. 2 receptors in rat retina. NeuroReport, 1991, 2, 429-432.
34. Nowak J. Z., Zawilska J. B.: Signal transduction mechanisms related to melatonin biosynthesis and receptors in the vertebrate retina. Adv. Pineal Res., 1994, 8, 215-227.
35. Nowak J. Z., Zawilska J. B.: Melatonin and its physiological and therapeutic properties. Pharm. World Sci., 1997, 19, in press.
36. Nowak J. Z., Żurawska E.: Dopamine in the rabbit retina and striatum: diurnal rhythm and effect of light stimulation. J. Neural Transm., 1989, 75, 201-212.
37. Nowak J. Z., Żurawska E.: Serotonin N-acetyltransferase (NAT) activity in hen retina and pineal gland: in vivo pharmacological induction at noon and antagonism of the light-evoked suppression at night. Neurochem. Int., 1989, 15, 567-573.
38. O'Dowd B. F.: Structures of dopamine receptors. J. Neurochem., 1993, 60, 804-816.
39. Parkinson D., Rando R. R.: Effects of light on dopamine metabolism in the chick retina. J. Neurochem., 1983, 40, 39-46.
40. 4 receptor. Mol. Pharmacol., 1996, 50, 1658-1664.
41. 4 receptor antagonist. Brit. J. Pharmacol., 1996, 119 Suppl., 30P.
42. Phillips S. T., de Paulis T., Neergaard J. R., Baron B. M., Siegel B. W., Seeman P., Van Tol H. H. M., Guan H. C., Smith H. E.: Binding of 5H-dibenzo[a,d]cycloheptane and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors. J. Med. Chem., 1995, 38, 708-714.
43. Roth R. H.: Neuroleptics: functional Neurochemistry. In: Neuroleptics: Neurochemical, Behavioral, and Clinical Perspectives. Ed. Coyle J. T., Raven Press, New York, 1983, 119-156.
44. 4 receptors. J. Med. Chem., 1996, 39, 1943-1945.
45. Rupniak N. M. J., Kilpatrick G., Hall M. D., Jenner P., Marsden C. D.: Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology, 1984, 84, 512-519.
46. 4 receptor. Eur. J. Pharmacol., 1997, 322, 283-286.
47. 4 receptors by 2-fold in rats. Eur. J. Pharmacol., 1995, 289, 67-72.
48. 2 receptors: characterization by binding or pharmacological studies and physiological functions. Cell. Mol. Neurobiol., 1990, 10, 303-325.
49. 4 receptors. Neuropsychopharmacology, 1997, 16, 93-110.
50. 4 receptors elevated in schizophrenia. Nature, 1993, 365, 441-445.
51. Strange P. G.: Dopamine receptors: studies on structure and function. Adv. Drug Res., 1996, 28, 313-351.
52. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res., 1995, 681, 109-116.
53. 4 receptor. Neurosci. Lett., 1995, 199, 69-72.
54. 4 antagonist. J. Med. Chem., 1996, 39, 2435-2437.
55. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 1991, 350, 610-614.
56. 2-adrenergic receptors. Life Sci., 1986, 39, 2025-2032.
57. 4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol. Pharmacol., 1996, 49, 656-661.
58. Witkovsky P., Dearry A.: Functional roles of dopamine in retina. In: Progress in Retinal Research. Eds. Osborne N. N., Chader G.J., Pergamon, Oxford, 1991, 247-292.
59. Zatz M., Mullen D. A.: Norepinephrine, acting via adenylate cyclase, inhibits melatonin output but does not phase-shift the pacemaker in cultured chick pineal cells. Brain Res., 1988, 450, 137-143.
60. Zawilska J. B.: Melatonin in vertebrate retina: biosynthesis, receptors and functions. Pol. J. Pharmacol. Pharm., 1992, 44, 627-654.
61. Zawilska J. B.: The role of calcium in the regulation of melatonin biosynthesis in the retina. Acta Neurobiol. Exp., 1992, 52, 265-274.
62. Zawilska J. B.: The role of dopamine in the regulation of melatonin biosynthesis in vertebrate retina. Acta Neurobiol. Exp., 1994, 54 Suppl., 47-56.
63. 4-like dopamine receptor suppresses serotonin N-acetyltransferase activity but does not phase-shift the circadian oscillator in chick retina. Neurosci. Lett., 1994, 179, 107-110.
64. Zawilska J. B.: Clonidine in vivo mimics the acute suppressive but not the phase-shifting effects of light on circadian rhythm of serotonin N-acetyltransferase activity in chick pineal gland. J. Pineal Res., 1994, 17, 63-68.
65. Zawilska J. B.: Melatonin as a chemical indicator of environmental light-dark cycle. Acta Neurobiol. Exp. 1996, 56, 757-767.
66. 4-like dopamine receptor. J. Neural Transm. - Gen. Sect., 1994, 97, 107-117.
67. 4-like receptors. J. Neural Transm., 1996, 103, 1405-1414.
68. 4-like receptor. J. Pineal Res., 1997, 22, 59-64.
69. Zawilska J. B., Derbiszewska T., Sek B., Nowak J. Z.: Dopamine-dependent cyclic AMP generating system in chick retina and its relation to melatonin biosynthesis. Neurochem. Int., 1995, 27, 535-543.
70. 2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland. J. Pharmacol. Exp. Ther., 1989, 250, 86-92.
71. Zawilska J. B., Nowak J. Z.: Regulatory mechanisms in melatonin biosynthesis in retina. Neurochem. Int., 1992, 20, 23-36.
72. 4-like subtype: pharmacological characterization. Neurochem. Int., 1994, 24, 275-280.
73. 4 dopamine receptor mediate the inhibitory effect of light on melatonin biosynthesis in chick retina? Neurosci. Lett., 1994, 166, 203-206.